Log in

VRL Vasundhara Rasayans Ltd. BSE · India

Vasundhara Rasayans (VRL) news

Vasundhara Rasayans Ltd. is a public biotech or pharmaceutical company listed on BSE under the ticker VRL, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Vasundhara Rasayans news

We have not published a story on Vasundhara Rasayans yet. When there is news, it will appear here.

Questions about Vasundhara Rasayans

What is the ticker symbol of Vasundhara Rasayans?

Vasundhara Rasayans Ltd. trades under the ticker VRL on BSE.

Where is Vasundhara Rasayans listed?

Vasundhara Rasayans Ltd. is listed on BSE.

Which country or territory is Vasundhara Rasayans listed under?

Our directory records Vasundhara Rasayans Ltd. under India.

What does Vasundhara Rasayans do?

Our directory classifies Vasundhara Rasayans Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Vasundhara Rasayans?

The ISIN recorded for Vasundhara Rasayans Ltd. is INE406F01010.

Does aibio.space cover Vasundhara Rasayans?

aibio.space lists Vasundhara Rasayans Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Vasundhara Rasayans?

Companies in our directory listed in the same country and business area as Vasundhara Rasayans: MPS PHARMAA LIMITED, Ambalal Sarabhai Enterprises, Kwality Pharmaceuticals, Alembic Pharmaceuticals, Parmax Pharma, Hikal.

Investor discussion: Vasundhara Rasayans

Members talk about Vasundhara Rasayans (VRL). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BSE:VRL on TradingView.

Listing details

Vasundhara Rasayans Ltd. is a public biotech or pharmaceutical company listed on BSE under the ticker VRL, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Vasundhara Rasayans Ltd.
Ticker
VRL
Listing
BSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE406F01010
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.